Reporting owner · CIK 0001468308

Andrade Robert

Visual SEC Form 4 history across 1 companies, 10 transactions and 7 filings.

CFOCHIEF FINANCIAL OFFICERFENNEC PHARMACEUTICALS INC.
Open-market mix
Latest filingSep 01, 2026, 12:09 AM
Filings7Form 4 records
Buying$00 purchases
Selling$883.5K1 sales
Net value−$883.5KBuys minus sells
Companies12 securities
Most recentAug 31, 2026grant

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Dec 24Jan 25Feb 25Dec 25Jan 261Aug 26

Net value flow

Buys minus sells

Dec 24
$0
Jan 25
$0
Feb 25
$0
Dec 25
$0
Jan 26
$0
Aug 26
−$883.5K

Transaction texture

Ownership and ticket size

Average P/S size$883.5K
Median P/S size$883.5K
Direct10
Indirect0
Aug 31, 2026grant

Filing-only signals

Deterministic matches in this insider's history

Derivative Transactionfiling-context2Direct Ownershipfiling-context10Large Holdings Reductionholdings110b5-1 Detectedfiling-context3

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at FENNEC PHARMACEUTICALS INC. on Aug 27, 2026 valued at $883,500.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at FENNEC PHARMACEUTICALS INC. on Aug 27, 2026 valued at $883,500.

Review SEC filing

Associated companies

Visual map of known reporting history

FENCFENNEC PHARMACEUTICALS INC.10 transactions · latest Sep 01, 2026, 12:09 AM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
FENCAndrade Robert
CFO
grant1.70k$0A
Direct Ownership
0.0%09/0108/31
FENCAndrade Robert
CFO
exercise10b5-121.9k$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
—08/2808/28
FENCAndrade Robert
CFO
exercise10b5-121.9k$11.1MM
Direct Ownership 10b5-1 Detected
—08/2808/28
FENCAndrade Robert
CFO
sale10b5-175.0k-$88.3MS
Direct Ownership Large Holdings Reduction 10b5-1 Detected
—08/2808/27
FENCAndrade Robert
CFO
exercise14.1k-$3.47MM
Derivative Transaction Direct Ownership
—01/0701/07
FENCAndrade Robert
CFO
exercise14.1k$3.47MM
Direct Ownership
—01/0701/07
FENCAndrade Robert
CFO
grant1.38k$0A
Direct Ownership
−16.5%01/0512/31/2025
FENCAndrade Robert
CFO
grant1.04k$0A
Direct Ownership
—02/28/202502/28/2025
FENCAndrade Robert
CFO
grant1.04k$0A
Direct Ownership
—02/03/202501/31/2025
FENCAndrade Robert
CFO
grant1.04k$0A
Direct Ownership
—01/03/202512/31/2024

Andrade Robert Insider Activity FAQ

SEC Form 4 context

Who is Andrade Robert?

Andrade Robert is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001468308.

Which companies has Andrade Robert reported transactions for?

FENNEC PHARMACEUTICALS INC.

When was Andrade Robert's latest insider buy?

No open-market insider purchase is available for this period.

When was Andrade Robert's latest insider sale?

sale at FENNEC PHARMACEUTICALS INC. on Aug 27, 2026 valued at $883,500.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.